Targeting CDK1 in cancer: mechanisms and implications

Q Wang, AM Bode, T Zhang - NPJ precision oncology, 2023 - nature.com
Cyclin dependent kinases (CDKs) are serine/threonine kinases that are proposed as
promising candidate targets for cancer treatment. These proteins complexed with cyclins …

[HTML][HTML] Biological functions of CDK5 and potential CDK5 targeted clinical treatments

A Shupp, MC Casimiro, RG Pestell - Oncotarget, 2017 - ncbi.nlm.nih.gov
Cyclin dependent kinases are proline-directed serine/threonine protein kinases that are
traditionally activated upon association with a regulatory subunit. For most CDKs, activation …

CDK9: a comprehensive review of its biology, and its role as a potential target for anti-cancer agents

AT Anshabo, R Milne, S Wang, H Albrecht - Frontiers in oncology, 2021 - frontiersin.org
Cyclin-dependent kinases (CDKs) are proteins pivotal to a wide range of cellular functions,
most importantly cell division and transcription, and their dysregulations have been …

The emerging role of Cdk5 in cancer

K Pozo, JA Bibb - Trends in cancer, 2016 - cell.com
Cdk5 is an atypical cyclin-dependent kinase that is well characterized for its role in the
central nervous system rather than in the cell cycle. However, Cdk5 has been recently …

Targeting CDK2 in cancer: challenges and opportunities for therapy

S Tadesse, AT Anshabo, N Portman, E Lim, W Tilley… - Drug discovery today, 2020 - Elsevier
Highlights•CDK2 has key roles in cell cycle, DNA replication and DNA damage.•Multiple
biomarkers can indicate increased CDK2 activity.•Some cancers have particular …

Targeting CDK12 for cancer therapy: function, mechanism, and drug discovery

H Liu, K Liu, Z Dong - Cancer research, 2021 - AACR
Abstract Cyclin-dependent kinase 12 (CDK12) is a member of the CDK family of proteins
(CDK) and is critical for cancer development. Years of study into CDK12 have generated …

CDK8 kinase—An emerging target in targeted cancer therapy

T Rzymski, M Mikula, K Wiklik, K Brzózka - Biochimica et Biophysica Acta …, 2015 - Elsevier
Cyclin-dependent kinase (CDK) inhibitors have been developed as potential anticancer
therapeutics and several nonselective compounds are currently in advanced clinical trials …

Targeting CDK6 in cancer: State of the art and new insights

S Tadesse, M Yu, M Kumarasiri, BT Le, S Wang - Cell Cycle, 2015 - Taylor & Francis
Cyclin-dependent kinase 6 (CDK6) plays a vital role in regulating the progression of the cell
cycle. More recently, CDK6 has also been shown to have a transcriptional role in tumor …

Cyclin-dependent kinase 2 inhibitors in cancer therapy: an update

S Tadesse, EC Caldon, W Tilley… - Journal of medicinal …, 2018 - ACS Publications
Cyclin-dependent kinase 2 (CDK2) drives the progression of cells into the S-and M-phases
of the cell cycle. CDK2 activity is largely dispensable for normal development, but it is …

Cyclin-dependent kinase 8: A new hope in targeted cancer therapy? Miniperspective

S Philip, M Kumarasiri, T Teo, M Yu… - Journal of medicinal …, 2017 - ACS Publications
Cyclin-dependent kinase 8 (CDK8) plays a vital role in regulating transcription either
through its association with the Mediator complex or by phosphorylating transcription factors …